Bernd Jilma

23.5k total citations · 2 hit papers
562 papers, 16.7k citations indexed

About

Bernd Jilma is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Bernd Jilma has authored 562 papers receiving a total of 16.7k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Hematology, 163 papers in Cardiology and Cardiovascular Medicine and 117 papers in Immunology. Recurrent topics in Bernd Jilma's work include Platelet Disorders and Treatments (106 papers), Antiplatelet Therapy and Cardiovascular Diseases (104 papers) and Venous Thromboembolism Diagnosis and Management (68 papers). Bernd Jilma is often cited by papers focused on Platelet Disorders and Treatments (106 papers), Antiplatelet Therapy and Cardiovascular Diseases (104 papers) and Venous Thromboembolism Diagnosis and Management (68 papers). Bernd Jilma collaborates with scholars based in Austria, United States and Germany. Bernd Jilma's co-authors include Jolanta M. Siller‐Matula, Alexander Spiel, James C. Gilbert, Oswald Wagner, Christa Firbas, Petra Stohlawetz, Florian Mayr, Michael Schwameis, Ulla Derhaschnig and Petra Jilma‐Stohlawetz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Bernd Jilma

546 papers receiving 16.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

2016 429 citations Bernd Jilma et al. profile →
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting

2019 286 citations Bernd Jilma, Alexander Röth et al. profile →

Peers

Countries citing papers authored by Bernd Jilma

Since Specialization

Citations

This map shows the geographic impact of Bernd Jilma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Jilma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Jilma more than expected).

Fields of papers citing papers by Bernd Jilma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Jilma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Jilma. The network helps show where Bernd Jilma may publish in the future.

Co-authorship network of co-authors of Bernd Jilma

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Jilma. A scholar is included among the top collaborators of Bernd Jilma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Jilma. Bernd Jilma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Landiolol for refractory ventricular fibrillation in out-of-hospital cardiac arrest: A randomized, double-blind, placebo-controlled, pilot trial 2024 ·Resuscitation ·Georg Gelbenegger, Bernd Jilma, (unknown), (unknown), Jolanta M. Siller‐Matula, Patrick Sulzgruber, (unknown), Thomas Hamp, (unknown), Sebastian Schnaubelt, Michael Hölzer, (unknown)	6
2	Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial 2024 ·Frontiers in Medicine ·(unknown), Renate Thalhammer, Christian Sillaber, Ulla Derhaschnig, Christa Firbas, Ulrich Jäger, Bernd Jilma, (unknown)	2
3	Fluid management for sepsis-induced hypotension in patients with advanced chronic kidney disease: a secondary analysis of the CLOVERS trial 2024 ·Critical Care ·Anselm Jorda, Ivor S. Douglas, Thomas Staudinger, Gottfried Heinz, Felix Bergmann, Rainer Oberbauer, Gürkan Sengölge, Markus Zeitlinger, Bernd Jilma, Nathan I. Shapiro, (unknown)	5
4	Torque Teno Virus Control by the Classical Pathway of Complement Activation—A Retrospective Analysis From a First‐in‐Human Trial Utilizing Sutimlimab 2024 ·Journal of Medical Virology ·(unknown), Jakob Mühlbacher, (unknown), (unknown), Farsad Eskandary, Martin Schiemann, Bernd Jilma, Georg A. Böhmig, Gregor Bond, Markus Wahrmann	2
5	The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo 2024 ·Journal of Thrombosis and Thrombolysis ·Juergen Grafeneder, Gero Langer, Christian Schoergenhofer, Farsad Eskandary, Bernd Jilma, Yasser Khder, (unknown)	1
6	The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1 2024 ·Blood ·Alain Chion, (unknown), Ferdows Atiq, (unknown), Sonia Águila, Judicaël Fazavana, (unknown), Ellie Karampini, (unknown), Roger J. S. Preston, Ross Baker, Thomas A. J. McKinnon, Shuhao Zhu, James C. Gilbert, Jonas Emsley, Bernd Jilma, James S. O’Donnell	15
7	Polyunsaturated Fatty Acid Intake during Complementary Feeding and Neurodevelopmental Outcome in Very Low Birth Weight Infants 2023 ·Nutrients ·(unknown), Margarita Thanhaeuser, Fabian Eibensteiner, Robin Ristl, Bernd Jilma, Renate Fuiko, Susanne Brandstetter, Angelika Berger, Nadja Haiden	4
8	Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial 2022 ·Trials ·Katharina A. Mayer, Klemens Budde, Philip F. Halloran, Konstantin Doberer, Lionel Rostaing, Farsad Eskandary, (unknown), Markus Wahrmann, Heinz Regele, Sabine Schranz, Sarah Ely, Christa Firbas, Christian Schörgenhofer, Alexander Kainz, Alexandre Loupy, Stefan Härtle, Rainer Boxhammer, Bernd Jilma, Georg A. Böhmig	15
9	Randomized Controlled Trial of Two Timepoints for Introduction of Standardized Complementary Food in Preterm Infants 2022 ·Nutrients ·Nadja Haiden, Margarita Thanhaeuser, Fabian Eibensteiner, (unknown), (unknown), Robin Ristl, (unknown), Susanne Brandstetter, (unknown), Christoph Binder, (unknown), Bernd Jilma	7
10	The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A 2022 ·Blood ·Cihan Ay, (unknown), (unknown), Christian Schoergenhofer, Georg Gelbenegger, Christa Firbas, Peter Quehenberger, Petra Jilma‐Stohlawetz, James C. Gilbert, Shuhao Zhu, Martin Béliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger	18
11	Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus 2022 ·JMIR Medical Informatics ·Peter Klimek, (unknown), Martin Brunner, (unknown), Gerhard Garhöfer, (unknown), (unknown), Bernd Jilma, (unknown), (unknown), (unknown), Herwig Ostermann, Claas Röhl, (unknown), Tanja Stamm, (unknown), (unknown), (unknown)	5
12	Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor 2022 ·JACC: Cardiovascular Interventions ·Francesco Franchi, Luis Ortega‐Paz, Fabiana Rollini, Mattía Galli, Latonya Been, (unknown), (unknown), (unknown), Andrea Rivas, (unknown), Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Birgit Reiter, Bernd Jilma, Dominick J. Angiolillo	18
13	Preterm Infants on Early Solid Foods and Vitamin D Status in the First Year of Life—A Secondary Outcome Analysis of a Randomized Controlled Trial 2022 ·Nutrients ·Margarita Thanhaeuser, Fabian Eibensteiner, (unknown), (unknown), Susanne Brandstetter, (unknown), Wolfgang Huf, (unknown), Christoph Binder, (unknown), Bernd Jilma, Angelika Berger, Nadja Haiden	2
14	Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism 2021 ·Transplant International ·Jakob Mühlbacher, Christian Schörgenhofer, Konstantin Doberer, Michael Dürr, Klemens Budde, Farsad Eskandary, Katharina A. Mayer, Sabine Schranz, Sarah Ely, Birgit Reiter, Edward Chong, Scott Adler, Bernd Jilma, Georg A. Böhmig	7
15	Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis 2020 ·Research and Practice in Thrombosis and Haemostasis ·Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay	286
16	Cold agglutinin disease: current challenges and future prospects 2019 ·SHILAP Revista de lepidopterología ·Sigbjørn Berentsen, Alexander Röth, Ulla Randen, Bernd Jilma, (unknown)	1
17	Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells 2019 ·Circulation Research ·Florian Puhm, Taras Afonyushkin, Ulrike Resch, Georg Obermayer, Manfred Rohde, T. Penz, Michael Schuster, Gabriel Wagner, André F. Rendeiro, Imène Melki, Christoph Kaun, Johann Wojta, Christoph Bock, Bernd Jilma, Nigel Mackman, Éric Boilard, Christoph J. Binder	201
18	Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial 2019 ·Trials ·Farsad Eskandary, Michael Dürr, Klemens Budde, Konstantin Doberer, Roman Reindl‐Schwaighofer, Johannes Waiser, Markus Wahrmann, Heinz Regele, Andreas Spittler, Nils Lachmann, Christa Firbas, Jakob Mühlbacher, Gregor Bond, (unknown), Edward Chong, Bernd Jilma, Georg A. Böhmig	41
19	Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy 2010 ·Critical Care Medicine ·(unknown), Alexander Spiel, Martin Frossard, Ulla Derhaschnig, Eva Riedmüller, Bernd Jilma	13
20	Effects of Carbon Monoxide Inhalation during Experimental Endotoxemia in Humans 2004 ·American Journal of Respiratory and Critical Care Medicine ·Florian Mayr, Alexander Spiel, Judith Leitner, Claudia Marsik, P. Germann, Roman Ullrich, Oswald Wagner, Bernd Jilma	153

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact